FI903931A7 - Neutrofiiliaktivoiva peptidi-2 - Google Patents

Neutrofiiliaktivoiva peptidi-2 Download PDF

Info

Publication number
FI903931A7
FI903931A7 FI903931A FI903931A FI903931A7 FI 903931 A7 FI903931 A7 FI 903931A7 FI 903931 A FI903931 A FI 903931A FI 903931 A FI903931 A FI 903931A FI 903931 A7 FI903931 A7 FI 903931A7
Authority
FI
Finland
Prior art keywords
neutrophil
activating peptide
peptide
activating
Prior art date
Application number
FI903931A
Other languages
English (en)
Finnish (fi)
Swedish (sv)
Other versions
FI903931A0 (fi
Inventor
Alfred Walz
Marco Baggiolini
Kenneth John Clemetson
Original Assignee
Sandoz Ag
Kocher Theodor Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from GB888828728A external-priority patent/GB8828728D0/en
Priority claimed from GB898909681A external-priority patent/GB8909681D0/en
Application filed by Sandoz Ag, Kocher Theodor Inst filed Critical Sandoz Ag
Publication of FI903931A0 publication Critical patent/FI903931A0/fi
Publication of FI903931A7 publication Critical patent/FI903931A7/fi

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/521—Chemokines
    • C07K14/522—Alpha-chemokines, e.g. NAP-2, ENA-78, GRO-alpha/MGSA/NAP-3, GRO-beta/MIP-2alpha, GRO-gamma/MIP-2beta, IP-10, GCP-2, MIG, PBSF, PF-4, KC
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/04—Immunostimulants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P7/00—Drugs for disorders of the blood or the extracellular fluid
    • A61P7/02—Antithrombotic agents; Anticoagulants; Platelet aggregation inhibitors
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/52—Cytokines; Lymphokines; Interferons
    • C07K14/54—Interleukins [IL]
    • C07K14/5421—IL-8
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Genetics & Genomics (AREA)
  • Biophysics (AREA)
  • Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Toxicology (AREA)
  • Zoology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Pain & Pain Management (AREA)
  • Dermatology (AREA)
  • Diabetes (AREA)
  • Rheumatology (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
  • Peptides Or Proteins (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
FI903931A 1988-12-08 1989-11-17 Neutrofiiliaktivoiva peptidi-2 FI903931A7 (fi)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
GB888828728A GB8828728D0 (en) 1988-12-08 1988-12-08 Neutrophil-stimulating activity i
GB898909681A GB8909681D0 (en) 1989-04-27 1989-04-27 Neutrophil-stimulating activity 1
PCT/EP1989/001389 WO1990006321A1 (en) 1988-12-08 1989-11-17 Neutrophil-activating peptide-2

Publications (2)

Publication Number Publication Date
FI903931A0 FI903931A0 (fi) 1990-08-08
FI903931A7 true FI903931A7 (fi) 1990-08-08

Family

ID=26294713

Family Applications (1)

Application Number Title Priority Date Filing Date
FI903931A FI903931A7 (fi) 1988-12-08 1989-11-17 Neutrofiiliaktivoiva peptidi-2

Country Status (19)

Country Link
US (1) US5759533A (enExample)
JP (1) JP3051160B2 (enExample)
KR (1) KR910700260A (enExample)
AU (1) AU634508B2 (enExample)
BE (1) BE1003636A4 (enExample)
CA (1) CA2004685A1 (enExample)
CH (1) CH681625A5 (enExample)
DK (1) DK188690D0 (enExample)
ES (1) ES2047458A6 (enExample)
FI (1) FI903931A7 (enExample)
FR (1) FR2640142B1 (enExample)
GB (1) GB2231872B (enExample)
GR (1) GR1000455B (enExample)
IL (1) IL92557A0 (enExample)
NL (1) NL8921262A (enExample)
NZ (1) NZ231652A (enExample)
PT (1) PT92509A (enExample)
SE (1) SE9002589L (enExample)
WO (1) WO1990006321A1 (enExample)

Families Citing this family (24)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH681625A5 (enExample) * 1988-12-08 1993-04-30 Sandoz Ag
AU7301091A (en) * 1990-02-01 1991-08-21 University Of South Florida Leukocyte-derived growth factor
US6673893B1 (en) * 1990-02-01 2004-01-06 University Of South Florida Leukocyte derived growth factor 2
AU2348492A (en) * 1991-07-19 1993-02-23 East Carolina University Method of treating asthma
WO1993009794A1 (en) * 1991-11-15 1993-05-27 University Of Pennsylvania Suppression of megakaryocytopoiesis by neutrophil activating peptide-2
WO1994016070A1 (en) * 1993-01-07 1994-07-21 University Of South Florida Leukocyte derived growth factors
US5786327A (en) 1993-03-12 1998-07-28 Gensci Regeneration Sciences Inc. Bone stimulating factor, methods of isolating same, and methods of increasing bone growth comprising administering same
US5578569A (en) * 1993-03-12 1996-11-26 Tam; Cherk S. Method of increasing bone growth
US6174995B1 (en) 1994-08-23 2001-01-16 Haodong Li Human chemokines, CKβ4 and CKβ10/MCP-4
US6391589B1 (en) 1994-08-23 2002-05-21 Human Genome Sciences, Inc. Human chemokine beta-10 mutant polypeptides
US6458349B1 (en) 1995-06-02 2002-10-01 Human Genome Sciences, Inc. Chemokine β-4 polypeptides
US5912232A (en) * 1994-09-23 1999-06-15 Board Of Regents Of The University Of Nebraska Anti-inflammatory polypeptide antagonists of human I1-8
US6352973B1 (en) 1995-06-07 2002-03-05 Osteopharm Inc. Bone stimulating factor
US5880094A (en) * 1995-06-07 1999-03-09 Osteopharm Limited Polypeptides that stimulate bone growth
US6117839A (en) * 1995-06-07 2000-09-12 Gensci Regeneration Sciences, Inc. Bone stimulating factor
US6693081B2 (en) * 1995-09-26 2004-02-17 Osteopharm Inc. Bone stimulating factor
US6290948B1 (en) 1996-05-14 2001-09-18 Smithkline Beecham Corporation Method of treating sepsis and ARDS using chamohine beta-10
US6838435B1 (en) 1997-09-25 2005-01-04 Academisch Ziekenhuis Bij De Universiteit Van Amsterdam Isolated and recombinant antimicrobial peptides thrombocidin-1 (TC-1) and thrombocidin-2(TC-2) or variants thereof
GB9807721D0 (en) 1998-04-08 1998-06-10 Chiron Spa Antigen
JP5500749B2 (ja) * 2000-03-07 2014-05-21 日本たばこ産業株式会社 好中球刺激活性を有するポリペプチド
US6815421B1 (en) 2001-03-22 2004-11-09 Osteopharm Inc. Polypeptides for use in ameliorating effects of aging in mammals
US7375192B2 (en) 2002-05-01 2008-05-20 Human Genome Sciences, Inc. Antibodies that specifically bind to chemokine beta-4
US7177246B2 (en) * 2003-09-12 2007-02-13 Hewlett-Packard Development Company, L.P. Optical disk drive focusing apparatus using sum signal
CN103874707B (zh) 2010-11-19 2017-04-19 卫材R&D管理有限公司 中和抗‑ccl20抗体

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4897348A (en) * 1983-08-25 1990-01-30 Sri International Recombinant materials and methods for producing human connective tissue-activating peptide-III and analogs thereof
DE3737703A1 (de) * 1987-11-06 1989-05-18 Ferring Arzneimittel Gmbh Neutrophilen aktivierendes polypeptid, verfahren zu dessen herstellung sowie dessen verwendung als arzneimittel und diagnostikum
US5026639A (en) * 1988-01-14 1991-06-25 Nippon Mining Company, Limited Method to improve mRNA translation and use thereof for production of platelet factor-4
CH681625A5 (enExample) * 1988-12-08 1993-04-30 Sandoz Ag

Also Published As

Publication number Publication date
CH681625A5 (enExample) 1993-04-30
IL92557A0 (en) 1990-08-31
JPH03503767A (ja) 1991-08-22
ES2047458A6 (es) 1994-02-16
NZ231652A (en) 1993-02-25
WO1990006321A1 (en) 1990-06-14
DK188690A (da) 1990-08-07
NL8921262A (nl) 1990-11-01
SE9002589D0 (sv) 1990-08-07
FI903931A0 (fi) 1990-08-08
DK188690D0 (da) 1990-08-07
US5759533A (en) 1998-06-02
AU634508B2 (en) 1993-02-25
JP3051160B2 (ja) 2000-06-12
GR890100810A (en) 1991-03-15
GB2231872A (en) 1990-11-28
KR910700260A (ko) 1991-03-14
AU4655689A (en) 1990-06-26
GR1000455B (el) 1992-07-30
SE9002589L (sv) 1990-08-07
PT92509A (pt) 1990-06-29
GB9011468D0 (en) 1990-08-29
FR2640142A1 (fr) 1990-06-15
CA2004685A1 (en) 1990-06-08
BE1003636A4 (fr) 1992-05-12
GB2231872B (en) 1992-07-22
FR2640142B1 (fr) 1994-09-23

Similar Documents

Publication Publication Date Title
FI903931A7 (fi) Neutrofiiliaktivoiva peptidi-2
ATA901789A (de) Somatostatinpeptid
BR8806093A (pt) Trepano
ATA900689A (de) Calcitoninpeptide
ATA172889A (de) Furanderivate
DE68927610D1 (de) Antikörper-Arzneimittel Konjugale
DE68926597D1 (de) Mikrorechner
BR8902098A (pt) Eletrolisador
DK113291A (da) Homogent enzymimmunassay
BR8906898A (pt) Jamela
DK84589D0 (da) Ekspressionsvektor
DE68926367D1 (de) Hydroxymethylcyclobutylpurine
DK119691D0 (da) Loeftesele
DD277186A3 (de) Waelzlagerseparator
KR900009566U (ko) 반 합
ATA91889A (de) Baukonstruktion
FI881572A7 (fi) Jyrä
IT8853293V0 (it) Lattina sdoppiata
DK595788A (da) Ekspressionsvektor
ZA899425B (en) Neutrophil-activating peptide-2
SE8803172D0 (sv) Provrorsforslutning
DK137688D0 (da) Gaffelloeftevogn
SE8802842D0 (sv) Forbindelselenk
DK102689D0 (da) Renoverbar lynlaas
BR6800108U (pt) Supercross

Legal Events

Date Code Title Description
FD Application lapsed
MM Patent lapsed

Owner name: THEODOR KOCHER INSTITUT

Owner name: SANDOZ AG